Merck to Acquire Terns Pharmaceuticals for $6.7B as Lilly Elevates Former Loxo Executives
Merck plans to acquire Terns Pharmaceuticals for $6.7 billion to enhance its cancer drug pipeline ahead of Keytruda patent expiry. Meanwhile, Eli Lilly boosts its oncology leadership by promoting former Loxo executives to key roles, shaping future business strategies.
· 71d ago
